Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum MEDRELEAF CORP T.LEAF

"MedReleaf Corp is engaged in the production and sale of cannabis for medical purposes as regulated by the ACMPR, pursuant to its Licences and, in particular, its Markham Commercial Licence."

TSX:LEAF - Post Discussion

MEDRELEAF CORP > Buy Aurora at $7.7 share now by buying MedreLeaf 20% discoun
View:
Post by dhesi11 on Jun 09, 2018 2:10pm

Buy Aurora at $7.7 share now by buying MedreLeaf 20% discoun

I am not sure why more ppl are not selling Aurora and buying Medreleaf. 

Lets do the math

at current ACB price at 9.3 x 3.575 (share exchange ratio for Medreleaf) =  33.2475. 

But Current Medreleaf is trading at 27.52 / 3.575 (share exchange ratio for Med) = 7.7

So that equates to a 20% discount. Plus most places allow for a 30% margin on Medreleaf instead of 50% on ACB. I know Scotia does. 

So hedge your bets and buy Medreleaf. I just dont know who doesnt want a 20% discount on something. Merger will happen as both companies have agreed and all supporters support it. 
Read more at https://www.stockhouse.com/companies/bullboard?symbol=t.acb&postid=28150082#wtcJUCCZQ6TorWH6.99
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities